Anti-IFN14/ IFNA14/ IFN-alphaH functional antibody

Anti-IFN14/ IFNA14/ IFN-alphaH functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IFNA14/IFNA14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0978-Ab-1/ GM-Tg-hg-SE0978-Ab-2Anti-Human IFNA14 monoclonal antibodyHuman
GM-Tg-rg-SE0978-Ab-1/ GM-Tg-rg-SE0978-Ab-2Anti-Rat IFNA14 monoclonal antibodyRat
GM-Tg-mg-SE0978-Ab-1/ GM-Tg-mg-SE0978-Ab-2Anti-Mouse IFNA14 monoclonal antibodyMouse
GM-Tg-cynog-SE0978-Ab-1/ GM-Tg-cynog-SE0978-Ab-2Anti-Cynomolgus/ Rhesus macaque IFNA14 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0978-Ab-1/ GM-Tg-felg-SE0978-Ab-2Anti-Feline IFNA14 monoclonal antibodyFeline
GM-Tg-cang-SE0978-Ab-1/ GM-Tg-cang-SE0978-Ab-2Anti-Canine IFNA14 monoclonal antibodyCanine
GM-Tg-bovg-SE0978-Ab-1/ GM-Tg-bovg-SE0978-Ab-2Anti-Bovine IFNA14 monoclonal antibodyBovine
GM-Tg-equg-SE0978-Ab-1/ GM-Tg-equg-SE0978-Ab-2Anti-Equine IFNA14 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0978-Ab-1/ GM-Tg-hg-SE0978-Ab-2; GM-Tg-rg-SE0978-Ab-1/ GM-Tg-rg-SE0978-Ab-2;
GM-Tg-mg-SE0978-Ab-1/ GM-Tg-mg-SE0978-Ab-2; GM-Tg-cynog-SE0978-Ab-1/ GM-Tg-cynog-SE0978-Ab-2;
GM-Tg-felg-SE0978-Ab-1/ GM-Tg-felg-SE0978-Ab-2; GM-Tg-cang-SE0978-Ab-1/ GM-Tg-cang-SE0978-Ab-2;
GM-Tg-bovg-SE0978-Ab-1/ GM-Tg-bovg-SE0978-Ab-2; GM-Tg-equg-SE0978-Ab-1/ GM-Tg-equg-SE0978-Ab-2
Products NameAnti-IFNA14 monoclonal antibody
Formatmab
Target NameIFNA14
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFNA14 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0978-Ag-1Recombinant multi-species IFN14/ IFNA14/ IFN-alphaH protein
    CytokineGM-Tg-g-SE0978-Ag-1interferon, alpha 14 (IFNA14) protein


    Target information

    Target IDGM-SE0978
    Target NameIFNA14
    Gene ID3448
    Gene Symbol and SynonymsIFN-alphaH,IFNA14,LEIF2H
    Uniprot AccessionP01570
    Uniprot Entry NameIFN14_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000228083
    Target ClassificationN/A

    The target: IFNA14, gene name: IFNA14, also named as IFN-alphaH, LEIF2H. Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.